A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation

Transplantation

Volumn 81, Issue 4, 2006, Pages 536-540

  Phillips, Simon D ^a   Maguire, Donal ^a   Deshpande, Rahul ^a   Muiesan, Paolo ^a   Bowles, Matthew J ^a   Rela, Mohamad ^a   Heaton, Nigel D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Autologous cell salvage; Perfusion; Transfusion

Indexed keywords

ALCOHOL;

ADULT; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; BLOOD VOLUME; CHOLESTASIS; CHRONIC LIVER DISEASE; COST EFFECTIVENESS ANALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETRANSPLANTATION; TIME SERIES ANALYSIS; VEIN BYPASS; VIRUS INFECTION;

ADULT; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; LONDON; MALE; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 33644615782     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000199318.17013.c5     Document Type: Article

References (13)

1. Wong JC, Torella F, Haynes SL, et al. Autologous versus allogeneic transfusion in aortic surgery: A multicenter randomised clinical trial. Ann Surg 2002; 235: 145-151.
2. Chamberland ME. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? Clin Infect Dis 2002; 34: 797-805.
3. Kemper RR, Menitove JE, Hanto DW. Cost Analysis of Intraoperative Blood Salvage During Liver Transplantation. Liver Transpl Surg 1997; 3: 513-517.
4. Duffy G, Tolley K. Cost Analysis of Autologous Blood Transfusion using cell salvage, compared with allogenic blood transfusion. Transfusion Med 1997; 7: 189-196.
5. Crémieux P, Barrett B, Anderson K, Slavin MB. Cost of Outpatient Blood Transfusion in Cancer Patients. J Clin Oncol 2000; 18: 2755-2761.
6. Allain JP. Genomic screening for blood-borne viruses in transfusion settings. Clin Lab Haematol 2000; 22: 1-10.
7. Simmonds P, Kurtz J, Tedder RS. The UK blood transfusion service: over a (patent) barrel? Lancet 2002; 18: 359: 1713-1714.
8. Cross MH. Cell salvage and leucodepletion. Perfusion 2001; 16 Suppl: 61-66.
9. Gordon PC, James MF, Spearman CW, et al. Decreasing blood product requirements after orthotopic liver transplantation. S Afr J Surg 2002; 40: 46-48.
10. Dzik WH, Jenkins R. Use of intraoperative blood salvage during orthotopic liver transplantation. Arch Surg 1985; 120: 946-948.
11. Williamson KR, Taswell HF, Rettke SR, Krom RA. Intraoperative autologous transfusion: Its role in orthotopic liver Transplantation. Mayo Clin Proc 1989; 64: 340-345.
12. Jones CC, Stammers AH, Fristoe LW, et al. Removal of hepatocarcinoma cells from blood via cell washing and filtration techniques. J Extra Corpor Technol 1999; 31: 169-176.
13. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jacob disease by blood transfusion. Lancet 2004; 363: 417-21.